Skip to main content
TipRanks
Go Ultimate75% OFF

Artiva Biotherapeutics, Inc. (ARTV) Drug Pipeline

490 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Allogeneic Nk CellsMyositis, Scleroderma, Systemic Sclerosis (Ssc), Refractory Rheumatoid Arthritis (Ra), Idiopathic Inflammatory Myopathies (Iims), Rheumatoid Arthritis (Ra, Iim, Sjogren Syndrome, Sjogrens DiseasePhase IIRecruitingAlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.May 19, 2025―
Cyclophosphamide, Fludarabine, Gcc2005Lymphoma, T-CellPhase IRecruitingPhase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell MalignanciesNov 19, 2024―
Rituximab, Cyclophosphamide, Fludarabine, Obinutuzumab, Ab-101Lupus Nephritis - Who Class Iii, Lupus Nephritis - Who Class Iv, Sle, Refractory Systemic Lupus ErythematosusPhase IRecruitingAB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus ErythematosusFeb 09, 2024―
Afm13, Cyclophosphamide, Fludarabine, Interleukin-2, Ab-101Peripheral T Cell Lymphoma, Relapsed Or Refractory Hodgkin LymphomaPhase IITerminatedPhase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCLMay 19, 2023―
Cyclophosphamide, Fludarabine, Ab-201Breast Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinomaphase1AndPhase2WithdrawnA Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid TumorsDec 23, 2022―
Rituximab, Bendamustine, Cyclophosphamide, Fludarabine, Interleukin-2, Ab-101Non Hodgkin Lymphomaphase1AndPhase2Active Not RecruitingAB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin LymphomaDec 04, 2020―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Artiva Biotherapeutics, Inc. (ARTV) have in its pipeline
Artiva Biotherapeutics, Inc. ARTV is currently developing the following drugs: Allogeneic Nk Cells, Cyclophosphamide, Fludarabine, Gcc2005, Rituximab, Cyclophosphamide, Fludarabine, Obinutuzumab, Ab-101, Afm13, Cyclophosphamide, Fludarabine, Interleukin-2, Ab-101, Cyclophosphamide, Fludarabine, Ab-201, Rituximab, Bendamustine, Cyclophosphamide, Fludarabine, Interleukin-2, Ab-101. These drug candidates are in various stages of clinical development as the company works toward FDA approval.